X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (4473) 4473
Publication (1111) 1111
Book Chapter (15) 15
Conference Proceeding (9) 9
Book Review (6) 6
Dissertation (5) 5
Magazine Article (5) 5
Book / eBook (1) 1
Paper (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
proviruses - genetics (2798) 2798
humans (2661) 2661
animals (2026) 2026
virology (1616) 1616
molecular sequence data (1364) 1364
base sequence (1230) 1230
viruses (1081) 1081
hiv-1 - genetics (982) 982
female (944) 944
proviruses (939) 939
index medicus (925) 925
proviruses - isolation & purification (882) 882
mice (857) 857
polymerase chain reaction (838) 838
male (822) 822
dna (769) 769
dna, viral - genetics (767) 767
cell line (736) 736
dna, viral - analysis (670) 670
research article (605) 605
immunology (604) 604
infectious diseases (591) 591
hiv (536) 536
hiv infections - virology (532) 532
infection (525) 525
adult (513) 513
virus replication (503) 503
amino acid sequence (494) 494
expression (487) 487
proviruses - physiology (468) 468
viral load (441) 441
hiv-1 - physiology (439) 439
research (421) 421
middle aged (405) 405
cells, cultured (393) 393
transfection (393) 393
cloning, molecular (386) 386
transcription, genetic (381) 381
microbiology (373) 373
retroviridae - genetics (369) 369
virus diseases (366) 366
hiv-1 - isolation & purification (364) 364
mutation (360) 360
biochemistry & molecular biology (358) 358
replication (353) 353
virus integration (350) 350
human-immunodeficiency-virus (347) 347
human t-lymphotropic virus 1 - genetics (339) 339
genes, viral (315) 315
hiv-1 (312) 312
rna (307) 307
multidisciplinary sciences (294) 294
long terminal repeat (292) 292
lymphocytes (291) 291
rna, viral - genetics (289) 289
hiv infections - drug therapy (288) 288
gene expression (287) 287
genome, viral (280) 280
cells (278) 278
polymerase chain reaction - methods (275) 275
aids (271) 271
genetics & heredity (267) 267
genetic aspects (265) 265
dna, viral - isolation & purification (261) 261
biotechnology & applied microbiology (260) 260
genetic vectors (255) 255
genomes (251) 251
analysis (244) 244
repetitive sequences, nucleic acid (244) 244
health aspects (243) 243
infections (242) 242
leukocytes, mononuclear - virology (242) 242
phylogeny (242) 242
sequence analysis, dna (241) 241
blotting, southern (240) 240
human t-lymphotropic virus 1 - isolation & purification (237) 237
cell biology (230) 230
identification (228) 228
dna, viral - blood (226) 226
gene (225) 225
gene expression regulation, viral (223) 223
genes (221) 221
sequences (221) 221
restriction mapping (220) 220
hiv-1 - drug effects (217) 217
recombination, genetic (216) 216
protein (212) 212
retrovirus (208) 208
type-1 (204) 204
immunodeficiency-virus type-1 (201) 201
in-vivo (201) 201
endogenous retroviruses - genetics (193) 193
aged (191) 191
proteins (191) 191
hiv infections - immunology (190) 190
hiv infection (189) 189
htlv-i (189) 189
plasmids (185) 185
leukemia virus, murine - genetics (184) 184
medicine, research & experimental (183) 183
more...
Library Location Library Location
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (4384) 4384
Japanese (30) 30
Russian (28) 28
French (20) 20
Spanish (12) 12
German (10) 10
Chinese (5) 5
Italian (1) 1
Portuguese (1) 1
Turkish (1) 1
Ukrainian (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Nature, ISSN 0028-0836, 08/2014, Volume 514, Issue 7524, pp. 633 - 637
Journal Article
Cell Host & Microbe, ISSN 1931-3128, 04/2017, Volume 21, Issue 4, pp. 494 - 506.e4
Journal Article
Proceedings of the National Academy of Sciences of the United States of America, ISSN 0027-8424, 11/2018, Volume 115, Issue 48, pp. E11341 - E11348
Journal Article
Immunity, ISSN 1074-7613, 03/2012, Volume 36, Issue 3, pp. 491 - 501
Journal Article
Nature, ISSN 0028-0836, 07/2012, Volume 487, Issue 7408, pp. 482 - 485
Despite antiretroviral therapy, proviral latency of human immunodeficiency virus type 1 (HIV-1) remains a principal obstacle to curing the infection(1).... 
CELLS | ACTIVATION | SUBEROYLANILIDE HYDROXAMIC ACID | MULTIDISCIPLINARY SCIENCES | IN-VIVO | VALPROIC ACID | INFECTION | HISTONE DEACETYLASE INHIBITORS | TYPE-1 | EXPRESSION | PCR | Gene Expression Regulation, Viral - drug effects | Humans | Hydroxamic Acids - adverse effects | Histone Deacetylase Inhibitors - administration & dosage | RNA, Viral - blood | Virus Latency - drug effects | Proviruses - drug effects | HIV-1 - growth & development | Proviruses - genetics | Hydroxamic Acids - administration & dosage | Anti-HIV Agents - therapeutic use | CD4-Positive T-Lymphocytes - virology | Hydroxamic Acids - pharmacology | Biomarkers - metabolism | HIV Infections - blood | Risk Assessment | HIV-1 - drug effects | CD4-Positive T-Lymphocytes - cytology | HIV Infections - virology | RNA, Viral - biosynthesis | CD4-Positive T-Lymphocytes - metabolism | Viremia - drug therapy | HIV-1 - genetics | Proviruses - growth & development | Histones - drug effects | Up-Regulation - drug effects | Acetylation - drug effects | Viremia - virology | HIV Infections - drug therapy | Histone Deacetylase Inhibitors - pharmacology | Histones - metabolism | CD4-Positive T-Lymphocytes - drug effects | Histone Deacetylase Inhibitors - adverse effects | Physiological aspects | Antiviral agents | HIV patients | Health aspects | Vorinostat | Antiretroviral drugs | Plasma | Cell culture | Lymphocytes | Human immunodeficiency virus--HIV | Genomes | Drug therapy | Drug dosages
Journal Article
Nature, ISSN 0028-0836, 07/2016, Volume 535, Issue 7613, pp. 556 - 560
Interruption of combination antiretroviral therapy in HIV-1-infected individuals leads to rapid viral rebound. Here we report the results of a phase IIa open... 
POTENT | REPLICATION | GENETIC-DETERMINANTS | BROADLY NEUTRALIZING ANTIBODIES | MULTIDISCIPLINARY SCIENCES | PASSIVE TRANSFER | SEQUENCE | CD4 BINDING | ANTIRETROVIRAL THERAPY | INFECTION | MONOCLONAL-ANTIBODIES | Anti-HIV Agents - pharmacology | Antibodies, Neutralizing - administration & dosage | Disease Reservoirs - virology | Humans | Middle Aged | Male | Proviruses - immunology | Anti-HIV Agents - administration & dosage | Tissue Distribution | Young Adult | HIV Infections - immunology | Proviruses - drug effects | Antibodies, Neutralizing - immunology | HIV-1 - growth & development | HIV Antibodies - immunology | HIV Envelope Protein gp160 - chemistry | Time Factors | Antibodies, Neutralizing - therapeutic use | Binding Sites - immunology | Adult | Anti-HIV Agents - therapeutic use | Female | HIV Antibodies - therapeutic use | Historically Controlled Study | Binding Sites - drug effects | HIV Envelope Protein gp160 - metabolism | Drug Administration Schedule | HIV-1 - drug effects | HIV Infections - virology | HIV Antibodies - administration & dosage | Viral Load - immunology | Proviruses - growth & development | HIV-1 - immunology | HIV Envelope Protein gp160 - antagonists & inhibitors | Adolescent | HIV Infections - drug therapy | Aged | HIV Envelope Protein gp160 - immunology | Viral Load - drug effects | CD4 Antigens - metabolism | Prevention | Antiviral agents | HIV antibodies | Dosage and administration | Host-virus relationships | Drug therapy, Combination | Drug therapy | Health aspects | HIV infection | Methods | Clinical trials | Antiretroviral drugs | Immunoglobulins | Human immunodeficiency virus--HIV | Binding sites
Journal Article
Nature, ISSN 0028-0836, 03/2017, Volume 543, Issue 7646, pp. 564 - 567
Journal Article
PLoS Pathogens, ISSN 1553-7366, 02/2013, Volume 9, Issue 2, p. e1003174
HIV-1 reservoirs preclude virus eradication in patients receiving highly active antiretroviral therapy (HAART). The best characterized reservoir is a small,... 
LOW-LEVEL VIREMIA | PLASMA VIREMIA | CD4(+) T-CELLS | MICROBIOLOGY | PERIPHERAL-BLOOD | BLOOD MONONUCLEAR-CELLS | LATENT HIV-1 | INFECTED INDIVIDUALS | VIROLOGY | ACTIVE ANTIRETROVIRAL THERAPY | IN-VIVO | IMMUNODEFICIENCY-VIRUS TYPE-1 | PARASITOLOGY | Proviruses - isolation & purification | Disease Reservoirs - virology | Humans | Middle Aged | DNA, Viral - analysis | Male | Leukocytes, Mononuclear - virology | RNA, Viral - genetics | Proviruses - genetics | Virus Integration - drug effects | Polymerase Chain Reaction | Adult | Female | DNA, Viral - drug effects | Leukocytes, Mononuclear - drug effects | HIV Infections - genetics | HIV Infections - virology | RNA, Viral - analysis | HIV - isolation & purification | Proviruses - growth & development | HIV - growth & development | Antiretroviral Therapy, Highly Active | HIV - genetics | HIV Infections - drug therapy | Aged | DNA, Viral - genetics | RNA, Viral - drug effects | Viral Load - drug effects | Longitudinal Studies | CD4-Positive T-Lymphocytes - drug effects | Physiological aspects | HIV patients | Virulence (Microbiology) | Research | T cells | Health aspects | Plasma | Clinical trials | Statistical methods | Infections | Genomes | Grants | Experiments | Acquired immune deficiency syndrome--AIDS | Lymphocytes | Normal distribution | Human immunodeficiency virus--HIV | Drug therapy | Deoxyribonucleic acid--DNA | AIDS | HIV | Acquired immune deficiency syndrome | Deoxyribonucleic acid | DNA | Human immunodeficiency virus
Journal Article